Brief: ZYUS Life Sciences Receives No Objection Letter from Health Canada for Proof-of-Concept Trial
30/07/2024 12:22
July 30 (Reuters) - ZYUS Life Sciences Corp ZYUS.V :
* ZYUS LIFE SCIENCES RECEIVES NO OBJECTION LETTER FROM
HEALTH
CANADA FOR PROOF-OF-CONCEPT TRIAL
* ZYUS LIFE SCIENCES CORP - RECEIVES NO OBJECTION LETTER
FROM
HEALTH CANADA
Source text for Eikon: ID:nBw6ml1r7a
Further company coverage: ZYUS.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Zyus Life Sciences
See all newsBrief: Zyus Life Sciences Announces Strategic Realignment To Prioritize Drug Development
Brief: Zyus Life Sciences Reports Preliminary Results From Ongoing Phase 2A Utopia-1 Trial
Brief: ZYUS Life Sciences Provides Update On Clinical Trial Progress And Unit Private Placement
Brief: Zyus Closes First Tranche Of Unit Offering, Issues Warrants Under Loan Agreements And Note Amendment
Brief: Zyus Life Sciences Corporation Announces Closing Of Additional Secured Loan